Literature DB >> 7964802

Antiglycolipid antibodies in peripheral neuropathy: fact or fiction?

H J Willison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7964802      PMCID： PMC1073177          DOI： 10.1136/jnnp.57.11.1303

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  89 in total

1.  Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease.

Authors:  G J Parry; S Clarke
Journal:  Muscle Nerve       Date:  1988-02       Impact factor: 3.217

2.  Serum antibodies to gangliosides in Guillain-Barré syndrome.

Authors:  A A Ilyas; H J Willison; R H Quarles; F B Jungalwala; D R Cornblath; B D Trapp; D E Griffin; J W Griffin; G M McKhann
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

3.  Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis.

Authors:  A Pestronk; R N Adams; L Clawson; D Cornblath; R W Kuncl; D Griffin; D B Drachman
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

4.  Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin.

Authors:  B Schwerer; H Lassmann; K Kitz; H Bernheimer
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

5.  Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease.

Authors:  N Latov; A P Hays; P D Donofrio; J Liao; H Ito; S McGinnis; M Konstadoulakis; L Freddo; M E Shy; K Manoussos
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

6.  Reactivity with the peripheral myelin glycoprotein P0 in serum from patients with monoclonal IgM gammopathy and polyneuropathy.

Authors:  E Bollensen; A J Steck; M Schachner
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

7.  A prospective study of acute idiopathic neuropathy. II. Antecedent events.

Authors:  J B Winer; R A Hughes; M J Anderson; D M Jones; H Kangro; R P Watkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

Review 8.  Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.

Authors:  R H Quarles; A A Ilyas; H J Willison
Journal:  Chem Phys Lipids       Date:  1986-12-15       Impact factor: 3.329

9.  Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein.

Authors:  A P Hays; N Latov; M Takatsu; W H Sherman
Journal:  Neurology       Date:  1987-02       Impact factor: 9.910

10.  Motor neuron syndrome and monoclonal IgM with antibody activity against gangliosides GM1 and GD1b.

Authors:  E Nardelli; A J Steck; T Barkas; M Schluep; F Jerusalem
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422
View more
  9 in total

Review 1.  Specificity of antiglycolipid antibodies.

Authors:  N Baumann
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.

Authors:  B Schwerer; A Neisser; H Bernheimer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Coupling of nerve growth factor to its receptor: inhibition by anti-GM3 ganglioside antibody.

Authors:  M Chakraborty; D Chatterjee
Journal:  Cell Mol Neurobiol       Date:  2001-02       Impact factor: 5.046

Review 4.  Multifocal motor neuropathy.

Authors:  E Nobile-Orazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

Review 5.  Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders.

Authors:  P Fredman; A Lekman
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

6.  Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.

Authors:  Mohamed M El-Difrawy; Nadia E Zaki; Hazem M Marouf; Mona W Ayad; Ahmed M Farag
Journal:  Int J Hematol       Date:  2011-12-17       Impact factor: 2.490

7.  The anti-oligosaccharide antibodies present in sera from patients with motor neuron disease and neuropathy recognize the N-glycolylneuraminic acid containing gangliotetrahexosyl oligosaccharide.

Authors:  M Carpo; E Nobile-Orazio; V Chigorno; S Sonnino
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

8.  A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

Authors:  H J Willison; G M O'Hanlon; G Paterson; J Veitch; G Wilson; M Roberts; T Tang; A Vincent
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

9.  Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.

Authors:  L H Van den Berg; H Kerkhoff; P L Oey; H Franssen; I Mollee; M Vermeulen; F G Jennekens; J H Wokke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.